Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy.

Hans Jørgen Nielsen Bjørn Gunnar NedrebøAlexander FossåJohn Roger AndersenJörg AssmusVigdis Halvorsen DagslandSimon Nitter DankelOddrun Anita GudbrandsenJohan FernøIren HjellestadMarianne Jensen HjermstadRonette L KolotkinHåvard Luong ThorsenGunnar MellgrenTone Nygaard Flølo

Published in: International journal of obesity (2005) (2022)

In routine health care, both SG and RYGB are safe procedures with significant long-term weight-loss, improvement of QOL and amelioration of comorbidities. Long-term weight-loss and remission rates of main obesity-related comorbidities were higher after RYGB.

Keyphrases

roux en y gastric bypass
weight loss
body weight
gastric bypass
bariatric surgery
healthcare
obese patients
weight gain
glycemic control
depressive symptoms
clinical practice
type diabetes
metabolic syndrome
body mass index
skeletal muscle
social media